DSGN
Design TherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-16
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
DSGN vs peer average
34/100
DSGN vs. peer average (D vs. C)
Grade spread
A 3 · C 4 · D 2 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
AUTL is the first available peer comparator.
Clinical-stage cell/gene therapy peer with similar mid-cap biotech volatility and program-driven binary readouts
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
DSGN
Design Therapeutics
AUTL
Autolus Therapeutics
Grade
D
A
Momentum
16
94
Value
41
41
Sentiment
73
53
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs AUTL
DSGN / AUTL
Grade Position
Below peers
DSGN vs. peer average (D vs. C)
34/100
Momentum
16
AUTLValue
41
DSGNSentiment
73
DSGNRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs DSGN
AUTL is the first peer returned for this comparison set.